JBJury Brandolini

Jury Brandolini

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jury Brandolini has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Chronobiological Prognostic Model for Resected Stage I Non-Small-Cell Lung Cancer

    by Giovanni Leuzzi, Pamela Minicozzi, Paolo Verderio, Chiara Maura Ciniselli, Michele Ferrari, Alessandro Pardolesi, Alessia Stanzi, Jury Brandolini, Luigi Rolli, Matteo Calderoni, et al.

    Objectives: Chronobiology may influence outcomes in non-small-cell lung cancer (NSCLC), but its prognostic role in early-stage disease remains unclear. We evaluated the association between perioperative chronobiological variables, systemic inflammation, and long-term outcomes after complete resection for stage I NSCLC. Methods: 587 patients who underwent curative-intent resection for pathological stage I NSCLC between 2009 and 2018 were retrospectively reviewed. Chronobiological and inflammatory variables included season of surgery (spring/summer [21st March–22nd September], autumn/winter [23rd September–20th March]), time of day, day of week, and preoperative (CRP0 levels: low ≤ 3 mg/L, high > 3 mg/L) and postoperative day-3 (CRP3 levels: low ≤ 126 mg/L, high > 126 mg/L) C-reactive protein levels. The cohort was randomly divided into training (70%) and testing (30%) sets to develop and validate a prognostic model for overall survival (OS), taking into consideration the follow-up time. Disease-free survival (DFS) was analyzed as a secondary endpoint. Results: Median follow-up was 6.7 years, with 80 deaths and 108 recurrences recorded. In the training set, older age (p = 0.0049), stage IB disease (p = 0.0301), high CRP0 (p = 0.0049), and high CRP3 (p = 0.0280) were associated with worse OS, while surgery performed during autumn/winter was associated with improved OS (p = 0.0312). The multivariate Cox model including age, stage, and season of surgery showed the best prognostic performance (C-index 0.67, 95% Bonferroni-adjusted CI 0.50–0.83) and was internally validated in the testing cohort (C-index 0.69, 95%CI 0.52–0.86). The resulting linear predictor remained associated with both OS and DFS in the overall population. Conclusions: A simple model integrating age, pathological stage, and season of surgery was associated with long-term outcomes after surgery in stage I NSCLC. This model provides an exploratory framework integrating host-, tumor-, and chronobiological dimensions of prognosis. These findings require external validation and further investigation of the biological mechanisms underlying seasonal variation.

  • Open Access

    Functional Recovery as a Survivorship Endpoint in Early-Stage NSCLC

    by Giovanni Leuzzi, Filippo Lococo, Beatrice Cosentino, Federica Sabia, Michele Ferrari, Alessandro Pardolesi, Alessia Stanzi, Jury Brandolini, Luigi Rolli, Matteo Calderoni, et al.

    Advances in screening, surgical techniques, perioperative care, and multimodality treatment have progressively expanded the population of long-term survivors with early-stage non-small cell lung cancer (NSCLC). However, disease-free survival does not necessarily correspond to complete functional recovery after curative-intent treatment. Many patients continue to experience persistent fatigue, dyspnea, reduced physical activity, impaired exercise tolerance, muscle loss, and deterioration in health-related quality of life despite adequate oncologic control. This narrative review discusses functional recovery as a survivorship endpoint in early-stage NSCLC, focusing on recovery trajectories, physiologic vulnerability, frailty, sarcopenia, rehabilitation, symptom burden, and emerging biologic frameworks such as allostatic load. Increasing evidence suggests that survivorship after NSCLC should not be interpreted exclusively according to recurrence or survival metrics, but also according to the ability to recover physiologic reserve, autonomy, and daily functioning after treatment. Functional recovery appears heterogeneous and influenced by multiple interacting factors, including baseline reserve, systemic inflammation, physical inactivity, behavioral adaptation, and cumulative stress burden. Rehabilitation strategies, structured symptom surveillance, and patient-reported outcomes may help identify vulnerable patients and improve long-term survivorship trajectories. Future survivorship models should probably integrate oncologic outcomes with longitudinal functional assessment to better characterize recovery patterns after treatment.


  • Open Access

    Posttraumatic transmediastinal pulmonary hernia: An extremely rare clinical entity

    by Jury Brandolini, Pietro Bertoglio, Kenji Kawamukai, Barbara Bonfanti, Sergio Nicola Forti Parri, Elena Garelli, Piergiorgio Solli


  • Open Access

    Robotic resection of mediastinal left vagus neurofibroma

    by Jury Brandolini, Francesca Ambrosi, Pietro Bertoglio, Barbara Bonfanti, Sergio Nicola Fortiparri, Elena Garelli, Kenji Kawamukai, Piergiorgio Solli

    Neurogenic tumors represent 10 to 34% of all mediastinal tumors and among them, neurofibroma originating from the vagus nerve are rare entities. We present a case of a neurofibroma with cystic degeneration originating from the left branch of the vagus nerve in a 27-years-old man without von Recklinghausen disease. A complete robotic resection of the mediastinal mass has been performed, with amputation of the vagus nerve enclosed in the mass. The postoperative course was uneventful and the patient was discharged in two days.


  • Four arms robotic left upper lobectomy performed with da Vinci Xi System

    by Alessandro Pardolesi, Luca Bertolaccini, Jury Brandolini, Piergiorgio Solli, Pierluigi Novellis, Giulia Veronesi

  • Robotic left internal mammary lymph nodes dissection

    by Alessandro Pardolesi, Luca Bertolaccini, Jury Brandolini, Piergiorgio Solli

  • Surgical treatment of synchronous multiple neuroendocrine lung tumours (case series): is more always better?

    by Jury Brandolini, Luca Bertolaccini, Alessandro Pardolesi, Piergiorgio Solli

    Pulmonary neuroendocrine lung tumours are uncommon neoplasm; the presence of multiple and synchronous lesions is rare, and few case report are described in the literature. We present a case series of three patients without particular symptom and radiologic finding of multiple synchronous pulmonary nodules. All the patients underwent surgical treatment; histopathologic examination revealed typical carcinoid tumours in all three cases (one patient has a synchronous atypical carcinoid). No oncological progressions were observed at follow-up. A review of current literature is also presented with a suggested strategy management.


  • Chondroblastoma of the rib in a 47-year-old man: a case report with a systematic review of literature

    by Jury Brandolini, Luca Bertolaccini, Alessandro Pardolesi, Maurizio Salvi, Mirca Valli, Piergiorgio Solli

    Chondroblastoma is an uncommon benign bone tumour arising typically in the epiphysis. Few cases of chondroblastoma of the rib have been reported in the literature. We describe a case of chondroblastoma of a 47-year-old man located in the body of the IX right rib. The patient presented a moderate right thoracic pain with an apparently palpable mass. Computed tomography (CT) scan showed a well-defined oval 49 mm × 43 mm lesion with the lytic bone destruction of the rib. A surgical resection was performed with an excellent outcome and no recurrence after 4-year follow-up. We also conducted a systematic review of literature where we evidenced that chondroblastoma could affect people of all age, but it’s most common in children and young adult. Surgical resection constitutes the treatment of choice.


  • Edited right upper lobectomy (robot daVinci Si)

    by Alessandro Pardolesi, Luca Bertolaccini, Jury Brandolini, Piergiorgio Solli

  • Four arms robotic left lower lobectomy

    by Alessandro Pardolesi, Luca Bertolaccini, Jury Brandolini, Piergiorgio Solli